IDEAS home Printed from https://ideas.repec.org/a/wly/jpamgt/v20y2001i2p358-364.html
   My bibliography  Save this article

Can We Protect Drug Users from Hepatitis C?

Author

Listed:
  • Harold A. Pollack

    (University of Michigan School of Public Health, Ann Arbor)

Abstract

No abstract is available for this item.

Suggested Citation

  • Harold A. Pollack, 2001. "Can We Protect Drug Users from Hepatitis C?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 20(2), pages 358-364.
    • Handle: RePEc:wly:jpamgt:v:20:y:2001:i:2:p:358-364
    DOI: 10.1002/pam.2114
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1002/pam.2114
    File Function: Link to full text; subscription required
    Download Restriction: no
    File URL: https://libkey.io/10.1002/pam.2114?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Hagan, H. & Des Jarlais, D.C. & Friedman, S.R. & Purchase, D. & Alter, M.J., 1995. "Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program," American Journal of Public Health, American Public Health Association, vol. 85(11), pages 1531-1537.
    2. Garfein, R.S. & Vlahov, D. & Galai, N. & Doherty, M.C. & Nelson, K.E., 1996. "Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 655-661.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Packham, Analisa, 2022. "Syringe exchange programs and harm reduction: New evidence in the wake of the opioid epidemic," Journal of Public Economics, Elsevier, vol. 215(C).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Harold A. Pollack, 2001. "Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users," Medical Decision Making, , vol. 21(5), pages 357-367, October.
    2. Chen, Huey T., 2010. "The bottom-up approach to integrative validity: A new perspective for program evaluation," Evaluation and Program Planning, Elsevier, vol. 33(3), pages 205-214, August.
    3. Shiell, Alan & Law, Matthew G, 2001. "The cost of hepatitis C and the cost-effectiveness of its prevention," Health Policy, Elsevier, vol. 58(2), pages 121-131, November.
    4. Lelutiu-Weinberger, Corina & Pouget, Enrique R. & Des Jarlais, Don D.C. & Cooper, Hannah L. & Scheinmann, Roberta & Stern, Rebecca & Strauss, Shiela M. & Hagan, Holly, 2009. "A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups," Social Science & Medicine, Elsevier, vol. 68(3), pages 579-590, February.
    5. Suparna Das & Jenevieve Opoku & Adam Allston & Michael Kharfen, 2018. "Detecting spatial clusters of HIV and hepatitis coinfections," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-13, September.
    6. Montoya, Isaac D. & Atkinson, John S. & Lichtiger, Benjamin & Whitsett, Donna D., 2003. "Prevalence of hepatitis C in a drug using and non-using welfare population," Health Policy, Elsevier, vol. 64(2), pages 221-228, May.
    7. Alexander Gutfraind & Basmattee Boodram & Nikhil Prachand & Atesmachew Hailegiorgis & Harel Dahari & Marian E Major, 2015. "Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-23, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:jpamgt:v:20:y:2001:i:2:p:358-364. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/journal/34787/home .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.